Day: June 1, 2021

Headwater Gold Inc. (the “Company” or “Headwater”) is pleased to announce that the Company has obtained the final receipt for its non-offering prospectus from the British Columbia Securities Commission on May 31, 2021. Vancouver, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Headwater Gold Inc. (the “Company” or “Headwater”) is pleased to announce that the Company has obtained the final receipt for its non-offering prospectus from the British Columbia Securities Commission on May 31, 2021. Headwater previously received conditional approval to list the Company’s common shares (the “Common Shares”) on the Canadian Securities Exchange (the “CSE”).  Having filed the Final Prospectus, the Company expects to complete its listing and to have the Common Shares commence trading on the...

New Chief Technology Officer (CTO) appointed to accelerate innovation and further strengthen organizational capabilities Continuing robust progress in advancing the MosaiQ transfusion diagnostics menu Actively preparing for commercialization of MosaiQ products through planned evaluation placements in Europe Exploring potential partnerships across a broad range of applications for the multimodal and multiplexing MosaiQ by Quotient system Continued strong Alba by Quotient revenues with high single digit growth in Q4 FY21, exceeded full-year guidance Further strengthened cash position through private placement of Convertible Senior NotesJERSEY, Channel Islands, June 01, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...

Retail turnover (including VAT) of Apranga Group amounted to EUR 18.6 million in May 2021 and has increased by 23.8% comparing to May 2020. In May 2021, the retail turnover of Apranga Group in Lithuania increased by 39.9% year-to-year, in Latvia decreased by 28.5% and in Estonia increased by 47.8%. Due to epidemic coronavirus (COVID-19) infection, from 16 December 2020, all the Group’s stores in Lithuania were temporarily closed. Stores in Lithuania with a separate entrance from outside and a sales area not exceeding 300 square meters had been open since 15 February 2021. All stores with a separate entrance from outside had been open since 15 March 2021. All Group’s stores have been reopened in Lithuania from 19 April 2021, however, stores operating in shopping malls were not allowed to work on weekends, unless they had separate entrance...

Media Release Copenhagen, Denmark, June 1, 2021 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer, Anthony Pagano and Chief Development Officer, Judith Klimovsky, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference 3:50 PM EDT on June 9, 2021 (9:50 PM CEST). A webcast of the fireside chat will be available on Genmab’s website at https://ir.genmab.com/events-and-presentations#content         About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies,...